Brain imaging may unlock early clues to autism in tuberous sclerosis

NCT ID NCT02461459

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study investigates whether advanced brain imaging and electrical recordings can predict the presence and severity of autism spectrum disorder (ASD) and intellectual disability (ID) in people with tuberous sclerosis complex (TSC). Researchers will follow participants over time, using yearly assessments and MRI scans to track brain structure and function. The goal is to identify biomarkers that could lead to earlier diagnosis and better understanding of these conditions in the context of TSC.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to earlier detection and better understanding of autism and intellectual disability in people with tuberous sclerosis complex, potentially guiding future treatments.
What could go wrong
This is an observational study, so it won't test a treatment. The findings may not apply to all individuals with TSC, and the biomarkers identified may not be definitive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45229, United States

  • Stanford University

    Palo Alto, California, 94304, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294, United States

  • University of California at Los Angeles

    Los Angeles, California, 90095, United States

  • University of Texas at Houston

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.